Granted Patent B2

US 12,408,974 · App. 16/874,467 · Granted Sep 9, 2025

Inventor: Scott Raymond Smith (Chaska, MN)

Assignee: Medtronic Ireland Manufacturing Unlimited Company

A61B18/1492A61B17/122A61B17/320068A61B18/02A61B18/06A61B18/16A61M25/0147A61B8/12A61B8/485A61B2017/00402A61B2017/00867A61B2017/320069A61B2018/00023A61B2018/00047A61B2018/00214A61B2018/0022A61B2018/00267A61B2018/00279A61B2018/00285A61B2018/00404A61B2018/00434A61B2018/00529A61B2018/00577A61B2018/00821A61B2018/00875A61B2018/0212A61B2018/048A61B2018/068A61B2018/1425A61B2018/1435A61B2018/1467A61B2018/1475A61B18/1815A61B2018/1861A61B18/22A61B18/24A61B2218/007A61M25/09A61N2007/0021A61N2007/0043

Abstract

Claims (38)

1. An actively-cooled neuromodulation device adapted for intravascular neuromodulation, the device comprising:

an elongated shaft comprising a proximal end portion and a distal end portion;

an inflatable, expandable member positioned at the distal end portion of the elongated shaft, the inflatable, expandable member being configured to transition from a non-inflated delivery configuration to an inflated deployment configuration,

wherein the inflatable, expandable member comprises a plurality of electrodes positioned along the inflatable, expandable member so as to provide a treatment pattern designed to provide increased perivascular treatment while reducing vessel wall injury,

wherein the elongated shaft comprises a lumen, wherein the lumen is adapted to operably couple to a pump configured to continuously infuse coolant into the inflatable, expandable member through an inlet of the inflatable, expandable member and cause the coolant to exit the inflatable, expandable member through an outlet tube while the inflatable, expandable member is in the inflated deployment configuration such that the actively-cooled neuromodulation device provides continuous circulation of the coolant within the inflatable, expandable member to provide cooling to the plurality of electrodes, wherein, when in the inflated deployment configuration, at least one of the plurality of electrodes is adapted to be in contact with a vessel wall; and

two or more lesion spacing indicators positioned and longitudinally spaced apart along the distal end portion of the elongated shaft to facilitate controlled spacing of lesion zones,

wherein all lesion spacing indicators of the device are positioned distally to all electrodes of the device, and

wherein a longitudinal spacing of directly adjacent lesion spacing indicators of the two or more spacing lesion indicators is greater than a longitudinal spacing between two directly adjacent electrodes of the plurality of electrodes.

2. The device of claim 1 , wherein a ratio of circumferential perivascular injury to circumferential vessel wall injury caused by the neuromodulation device is greater than or equal to 2:1.

3. The device of claim 1 , wherein the two or more spaced apart lesion spacing indicators comprise radiopaque markers.

4. The device of claim 1 , wherein each of the electrodes comprises an oblong shape.

5. The device of claim 1 , wherein the plurality of electrodes are configured to function as monopolar electrodes.

6. The device of claim 1 , wherein at least two electrodes of the plurality of electrodes are positioned 180 degrees offset from each other.

7. The device of claim 1 , wherein each of the electrodes has an area of between 3 mm 2 and 16 mm 2 .

8. The device of claim 1 , wherein each electrode of the plurality of electrodes is configured to be connected to a radiofrequency generator by a separate connection wire such that each of the electrodes is individually controllable.

9. An actively-cooled neuromodulation device adapted for intravascular neuromodulation, the device comprising:

an elongated shaft comprising a proximal end portion and a distal end portion;

an inflatable, expandable member positioned at the distal end portion of the elongated shaft, the inflatable, expandable member being configured to transition from a non-inflated delivery configuration to an inflated deployment configuration so as to cause the inflatable, expandable member to be in contact with a vessel wall,

wherein the inflatable, expandable member comprises a plurality of electrodes positioned along an outer surface of the inflatable, expandable member so as to provide a treatment pattern that provides increased perivascular treatment while reducing vessel wall injury such that a ratio of circumferential perivascular treatment to circumferential vessel wall injury caused by the neuromodulation device is greater than or equal to 2:1,

wherein the elongated shaft comprises a lumen,

wherein the neuromodulation device is adapted to couple to a pump configured to continuously infuse coolant into the inflatable, expandable member through the lumen of the elongated shaft and into an inlet of the inflatable, expandable member and to cause the coolant to exit the inflatable, expandable member through an outlet tube while the inflatable, expandable member is in the inflated deployment configuration, such that the actively-cooled neuromodulation device provides continuous circulation of the coolant within the inflatable, expandable member to provide cooling to the plurality of electrodes,

wherein each of the electrodes is configured to be connected to a radiofrequency generator by a separate connection wire such that each of the electrodes is individually controllable,

wherein, when in the inflated deployment configuration, at least one of the plurality of electrodes is adapted to be in contact with the vessel wall; and

two or more lesion spacing indicators positioned along the distal end portion of the elongated shaft to facilitate controlled spacing between multiple lesion zones,

wherein all lesion spacing indicators of the device are positioned distally to all electrodes of the device, and

wherein a longitudinal spacing of directly adjacent lesion spacing indicators of the two or more spacing lesion indicators is greater than a longitudinal spacing between two directly adjacent electrodes of the plurality of electrodes to facilitate a minimum longitudinal spacing between adjacent lesion zones of the multiple lesion zones.

10. The device of claim 9 , wherein the plurality of electrodes comprises a plurality of electrode arrays.

11. The device of claim 10 , wherein each electrode array comprises a plurality of spaced-apart electrodes.

12. The device of claim 11 , wherein the plurality of electrode arrays are arranged to form a spiral pattern along the outer surface of the inflatable, expandable member.

13. The device of claim 9 , wherein the inflatable, expandable member comprises four and only four electrodes.

14. The device of claim 9 , wherein the inflatable, expandable member comprises a coating covering an entire outer surface of the inflatable, expandable member except for active electrode areas of the electrodes.

15. The device of claim 9 wherein the two or more lesion spacing indicators comprise radiopaque markers.

16. The device of claim 9 , wherein each of the electrodes comprises an oblong shape.

17. The device of claim 9 , further comprising means for assessing contact based on impedance.

18. The device of claim 9 , wherein each electrode of the plurality of electrodes is configured to function as a monopolar electrode.

19. The device of claim 9 , wherein at least two electrodes of the plurality of electrodes are positioned 180 degrees offset from each other.

20. The device of claim 9 , wherein each of the electrodes has an area of between 4 mm 2 and 10 mm 2 .

21. The device of claim 9 , wherein the two directly adjacent electrodes of the plurality of electrodes are circumferentially offset from each other.

Assignments (9)

Continuity (4)

References Cited (400)